Osaic Holdings
MREO

Osaic Holdings’s Mereo BioPharma MREO Stock Holding History

Osaic Holdings’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479 Hold
1,500
– – ﹤0.01% 7661
2026
Q1 		$495 Buy
1,500
+1,000
+200% +$429 ﹤0.01% 7441
2025
Q4 		$208 Sell
500
-5,177
-91% -$9.85K ﹤0.01% 7577
2025
Q3 		$9.71K Buy
5,677
+300
+6% +$553 ﹤0.01% 6379
2025
Q2 		$14.6K Buy
5,377
+2,314
+76% +$5.58K ﹤0.01% 5931
2025
Q1 		$6.89K Buy
3,063
+2,934
+2,274% +$8.3K ﹤0.01% 6000
2024
Q4 		$452 Buy
+129
New +$507 ﹤0.01% 7040
2021
Q1 		– Sell
-410
Closed -$1K – 6892
2020
Q4 		$1K Buy
+410
New +$1.03K ﹤0.01% 6237

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Osaic Holdings's MREO Position: Q2 2026 in Review

Osaic Holdings held its Mereo BioPharma (MREO) position steady in Q2 2026 at 1,500 shares worth $479. The position accounts for ﹤0.01% of the portfolio, ranked #7661.

Osaic Holdings first reported a position in MREO in Q4 2020 and has held it in 8 quarters since. The position peaked at $14.6K in Q2 2025. 60 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Osaic Holdings held 1,500 shares of Mereo BioPharma worth $479 as of Q2 2026.
  • Osaic Holdings left its Mereo BioPharma share count unchanged in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7661 holding.
  • Osaic Holdings first reported a position in Mereo BioPharma in Q4 2020 and has held it in 8 quarters since.
  • Osaic Holdings's Mereo BioPharma position peaked at $14.6K in Q2 2025.
  • 60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.